Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials
- Resource Type
- Review Article
- Source
- In
Critical Reviews in Oncology / Hematology May 2016 101:12-20 - Subject
- Language
- ISSN
- 1040-8428